Compare AbCellera Biologics Inc (ABCL) vs Direxion Daily 20 Year Treasury Bull 3X Shares (TMF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Direxion Daily 20 Year Treasury Bull 3X Shares — how do they compare? AbCellera Biologics Inc trades at $11.64 (market cap $3.68B), while Direxion Daily 20 Year Treasury Bull 3X Shares trades at $31.02. The key difference: AbCellera Biologics Inc is trading nearer its 52-week high, Direxion Daily 20 Year Treasury Bull 3X Shares nearer its low. Which is the better fit depends on your goals.
| ABCL | TMF | |
|---|---|---|
Market Cap | $3.68B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $12.50 | $44.14 |
52-Week Low | $2.78 | $29.83 |
Enterprise Value | $3.28B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABCL trades at $11.36, up 0.71% today, with a bullish technical signal and strong analyst support. Recent Phase 2 trial success for ABCL635 drove a 33% intraday surge in August 2026, though the company reports negative net income margins and operating cash outflows. Revenue declined from $485M in 2022 to $75M in 2025, reflecting ongoing challenges in profitability despite clinical progress.
The stock offers upside to the $15.50 consensus price target but carries high risk due to persistent losses and cash burn. Investment appeal hinges on ABCL635's regulatory success and future revenue generation, while dilution from a $200M August 2026 offering and competitive pressures pose headwinds.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Direxion Daily 20 Year Treasury Bull 3X Shares
TMF is a leveraged ETF that seeks to provide 300% (3x) of the daily performance of the ICE U.S. Treasury 20+ Year Bond Index. It is a tactical instrument used by sophisticated traders to capitalize on declining interest rates or to hedge against equity market volatility. Due to its daily reset mechanism and high expense ratio, TMF is structurally designed for short-term speculation rather than long-term buy-and-hold investing.
Read more on TMF →
